Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

Self-administration of the grass allergen tablet was safe. The treatment did not impair asthma control and confirmed considerable symptom prevention and reduced medication use. It addresses the allergic condition and represents a baseline treatment for grass pollen allergy.